NO20092530L - Genetiske markorer for risikohandtering av hjertearrytmi - Google Patents
Genetiske markorer for risikohandtering av hjertearrytmiInfo
- Publication number
- NO20092530L NO20092530L NO20092530A NO20092530A NO20092530L NO 20092530 L NO20092530 L NO 20092530L NO 20092530 A NO20092530 A NO 20092530A NO 20092530 A NO20092530 A NO 20092530A NO 20092530 L NO20092530 L NO 20092530L
- Authority
- NO
- Norway
- Prior art keywords
- cardiac arrhythmia
- atrial fibrillation
- risk management
- genetic markers
- markers
- Prior art date
Links
- 206010003119 arrhythmia Diseases 0.000 title abstract 2
- 230000002068 genetic effect Effects 0.000 title 1
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 208000006011 Stroke Diseases 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8576A IS8576A (is) | 2006-12-05 | 2006-12-05 | Genetic susceptibility variants of atrial fibrillation and stroke |
| IS8658 | 2007-06-29 | ||
| PCT/IS2007/000021 WO2008068780A2 (fr) | 2006-12-05 | 2007-12-05 | Marqueurs génétiques pour la gestion de risque de l'arythmie cardiaque |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092530L true NO20092530L (no) | 2009-09-03 |
Family
ID=39133840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092530A NO20092530L (no) | 2006-12-05 | 2009-07-03 | Genetiske markorer for risikohandtering av hjertearrytmi |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8637244B2 (fr) |
| EP (1) | EP2121979B1 (fr) |
| JP (1) | JP5646174B2 (fr) |
| KR (2) | KR20150113216A (fr) |
| AU (1) | AU2007330306B2 (fr) |
| BR (1) | BRPI0720116B8 (fr) |
| CA (1) | CA2673123C (fr) |
| DK (1) | DK2121979T3 (fr) |
| EA (1) | EA017529B1 (fr) |
| IL (1) | IL199049A (fr) |
| MX (1) | MX2009005651A (fr) |
| NO (1) | NO20092530L (fr) |
| NZ (1) | NZ577805A (fr) |
| SG (1) | SG177185A1 (fr) |
| WO (1) | WO2008068780A2 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ577805A (en) * | 2006-12-05 | 2012-09-28 | Decode Genetics Ehf | Genetic markers for risk management of cardiac arrhythmia |
| CA2751090A1 (fr) * | 2009-01-30 | 2010-08-05 | Electrophoretics Limited | Procede de diagnostic in vitro d'accident vasculaire cerebral |
| EP2414543B1 (fr) * | 2009-04-03 | 2016-10-12 | Decode Genetics EHF | Marqueurs génétiques pour la gestion de risque d'une fibrillation auriculaire et d'un accident vasculaire cérébral |
| US20120264636A1 (en) * | 2009-10-07 | 2012-10-18 | Decode Genetics Ehf. | Genetic variants indicative of vascular conditions |
| EP2548018A4 (fr) * | 2010-03-19 | 2013-08-07 | Cardio Dx Inc | Détermination d'une prédisposition à un événement cardiaque soudain |
| US20110301479A1 (en) * | 2010-06-03 | 2011-12-08 | Medtronic, Inc. | System and Method for Assessing a Likelihood of a Patient to Experience a Future Cardiac Arrhythmia Using Dynamic Changes in a Biological Parameter |
| WO2012000119A1 (fr) * | 2010-07-02 | 2012-01-05 | Prognomix Inc. | Méthode pour déterminer la prédisposition d'un sujet à la fibrillation auriculaire |
| WO2012016150A2 (fr) * | 2010-07-29 | 2012-02-02 | The Board Of Trustees Of The University Of Illinois | Procédés de prédiction du risque d'accident vasculaire cérébral |
| KR101230088B1 (ko) * | 2010-11-24 | 2013-02-05 | 연세대학교 산학협력단 | 심방세동의 예후 예측 방법 |
| KR101331787B1 (ko) * | 2011-10-04 | 2013-11-21 | 한국과학기술연구원 | 심장 부정맥 진단용 바이오마커 및 이를 이용한 심장 부정맥 진단 방법 |
| CN103998938B (zh) * | 2011-10-17 | 2016-06-15 | 霍夫曼-拉罗奇有限公司 | 风险患者和中风原因的基于肌钙蛋白和bnp的诊断 |
| EP2795338A4 (fr) * | 2011-12-21 | 2015-11-04 | Nuclea Biotechnologies Inc | Biomarqueurs d'insuffisance cardiaque congestive |
| MX357392B (es) | 2012-04-02 | 2018-07-06 | Berg Llc | Ensayos basados en interrogatorios celulares y uso de los mismos. |
| KR101462006B1 (ko) * | 2013-07-23 | 2014-11-18 | 한국과학기술연구원 | 심장 부정맥 진단용 바이오마커 및 이를 이용한 심장 부정맥 진단 방법 |
| CA2920835A1 (fr) | 2013-08-20 | 2015-02-26 | Anutra Medical, Inc. | Systeme de remplissage de seringue et procede associe |
| USD750768S1 (en) | 2014-06-06 | 2016-03-01 | Anutra Medical, Inc. | Fluid administration syringe |
| USD763433S1 (en) | 2014-06-06 | 2016-08-09 | Anutra Medical, Inc. | Delivery system cassette |
| USD774182S1 (en) | 2014-06-06 | 2016-12-13 | Anutra Medical, Inc. | Anesthetic delivery device |
| CN114203296B (zh) * | 2014-09-11 | 2025-10-17 | 布普格生物制药公司 | 基于患者数据的用于健康护理诊断和治疗的贝叶斯因果关系网络模型 |
| US10678367B1 (en) * | 2015-09-11 | 2020-06-09 | Apple Inc. | Compressive touch sensing |
| AU2016326742B2 (en) * | 2015-09-24 | 2022-04-28 | Caris Science, Inc. | Method, apparatus, and computer program product for analyzing biological data |
| KR101883657B1 (ko) * | 2016-05-13 | 2018-07-31 | 연세대학교 산학협력단 | 단일염기다형성에 의한 심방세동의 예측 또는 진단에 관한 정보 제공 방법 |
| RU2657942C1 (ru) * | 2017-07-25 | 2018-06-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования Читинская государственная медицинская академия Министерства здравоохранения российской федерации | Способ прогнозирования риска развития фибрилляции предсердий у женщин с ишемической болезнью сердца |
| RU2664430C1 (ru) * | 2017-12-14 | 2018-08-17 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития инсульта у мужчин на основе генетического тестирования |
| CN109324189B (zh) * | 2018-08-15 | 2021-10-01 | 泰达国际心血管病医院 | 多蛋白组合物的应用及先天性心脏病筛查试剂盒 |
| KR20210072013A (ko) * | 2018-11-02 | 2021-06-16 | (주)셀트리온 | 비후성 심근증 치료용 약학 조성물 |
| US12117453B2 (en) | 2018-12-07 | 2024-10-15 | Washington University | Predicting patient response to sodium channel blockers |
| JP7165100B2 (ja) * | 2019-04-23 | 2022-11-02 | ジェネシスヘルスケア株式会社 | 心房細動及び／又は心室細動のリスクを判定する方法 |
| WO2021118796A1 (fr) * | 2019-12-13 | 2021-06-17 | Ischemia Care Llc | Biomarqueurs pour le diagnostic d'un accident vasculaire cérébral causé par une fibrillation auriculaire |
| KR102250719B1 (ko) * | 2020-01-07 | 2021-05-11 | 고려대학교 산학협력단 | 발작성 심방세동 환자의 재발 위험도 예측을 위한 바이오 마커 |
| US20230332236A1 (en) * | 2020-10-08 | 2023-10-19 | Ischemia Care Llc | Method for diagnosing stroke utilizing gene expression signatures |
| WO2022082261A1 (fr) * | 2020-10-20 | 2022-04-28 | Genetic Technologies Limited | Procédés d'évaluation du risque de développer une maladie |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5288611A (en) * | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| ATE202801T1 (de) * | 1983-01-10 | 2001-07-15 | Gen Probe Inc | Verfahren zum nachweis, identifizieren und quantifizieren von organismen und viren |
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0436597B1 (fr) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Production et selection de proteines de liaison diversifiees de recombinaison |
| US5424186A (en) * | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5288644A (en) * | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| CA2095633C (fr) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Methode d'enrichissement de proteines variantes aux proprietes liantes alterees |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| EP1820858B1 (fr) | 1991-03-01 | 2009-08-12 | Dyax Corporation | Protéine chimère comprenant des micro-protéines dotées de deux liaisons disulfure ou plus et ses modes de réalisation |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| ATE198358T1 (de) | 1992-04-27 | 2001-01-15 | Dartmouth College | Detektion von gensequenzen in biologischen flüssigkeiten |
| US5858659A (en) * | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5837832A (en) * | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| WO2004028341A2 (fr) * | 2001-03-19 | 2004-04-08 | Decode Genetics Ehf. | Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement |
| NZ577805A (en) * | 2006-12-05 | 2012-09-28 | Decode Genetics Ehf | Genetic markers for risk management of cardiac arrhythmia |
-
2007
- 2007-12-05 NZ NZ577805A patent/NZ577805A/xx not_active IP Right Cessation
- 2007-12-05 JP JP2009539875A patent/JP5646174B2/ja not_active Expired - Fee Related
- 2007-12-05 EA EA200970578A patent/EA017529B1/ru not_active IP Right Cessation
- 2007-12-05 WO PCT/IS2007/000021 patent/WO2008068780A2/fr not_active Ceased
- 2007-12-05 BR BRPI0720116A patent/BRPI0720116B8/pt not_active IP Right Cessation
- 2007-12-05 CA CA2673123A patent/CA2673123C/fr not_active Expired - Fee Related
- 2007-12-05 EP EP07859637.6A patent/EP2121979B1/fr active Active
- 2007-12-05 KR KR1020157026224A patent/KR20150113216A/ko not_active Withdrawn
- 2007-12-05 MX MX2009005651A patent/MX2009005651A/es active IP Right Grant
- 2007-12-05 KR KR1020097013898A patent/KR101582321B1/ko not_active Expired - Fee Related
- 2007-12-05 US US12/302,463 patent/US8637244B2/en active Active
- 2007-12-05 SG SG2011089935A patent/SG177185A1/en unknown
- 2007-12-05 DK DK07859637.6T patent/DK2121979T3/en active
- 2007-12-05 AU AU2007330306A patent/AU2007330306B2/en not_active Ceased
-
2009
- 2009-06-01 IL IL199049A patent/IL199049A/en active IP Right Grant
- 2009-07-03 NO NO20092530A patent/NO20092530L/no not_active Application Discontinuation
-
2014
- 2014-01-13 US US14/153,926 patent/US20140227693A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2673123A1 (fr) | 2008-06-12 |
| CA2673123C (fr) | 2019-04-30 |
| MX2009005651A (es) | 2009-06-08 |
| EP2121979B1 (fr) | 2017-07-12 |
| WO2008068780A3 (fr) | 2008-10-09 |
| NZ577805A (en) | 2012-09-28 |
| AU2007330306A1 (en) | 2008-06-12 |
| DK2121979T3 (en) | 2017-09-25 |
| SG177185A1 (en) | 2012-01-30 |
| US8637244B2 (en) | 2014-01-28 |
| BRPI0720116A2 (pt) | 2014-01-14 |
| BRPI0720116B1 (pt) | 2018-05-02 |
| US20140227693A1 (en) | 2014-08-14 |
| KR20090087494A (ko) | 2009-08-17 |
| EA017529B1 (ru) | 2013-01-30 |
| EA200970578A1 (ru) | 2009-12-30 |
| KR101582321B1 (ko) | 2016-01-05 |
| IL199049A (en) | 2014-09-30 |
| JP5646174B2 (ja) | 2014-12-24 |
| BRPI0720116B8 (pt) | 2021-07-27 |
| US20090325163A1 (en) | 2009-12-31 |
| EP2121979A2 (fr) | 2009-11-25 |
| JP2010511404A (ja) | 2010-04-15 |
| KR20150113216A (ko) | 2015-10-07 |
| WO2008068780A2 (fr) | 2008-06-12 |
| AU2007330306B2 (en) | 2013-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092530L (no) | Genetiske markorer for risikohandtering av hjertearrytmi | |
| WO2009149319A3 (fr) | Profils d’expression de gène associés à des crises d’exacerbation d’asthme | |
| WO2008082730A3 (fr) | Biomarqueurs de modulation cible, efficacité, diagnostic et/ou pronostic pour les inhibiteurs de la raf | |
| WO2008146309A3 (fr) | Variantes génétiques sur les chr 5p12 et 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
| WO2009059321A3 (fr) | Analyse de lieu de rca pour estimer la sensibilité à l'amd et au mpgnii | |
| EP2663656A1 (fr) | Variants génétiques comme marqueurs à utiliser dans l'évaluation du risque, le diagnostic, le pronostic et le traitement du cancer de la vessie | |
| WO2009038742A3 (fr) | Procédé pour estimer le risque d'une lésion rénale aiguë | |
| PE20121029A1 (es) | Marcadores de riesgo para enfermedad cardiovascular | |
| NZ591236A (en) | Methods for determining a breeding value based on a plurality of genetic markers | |
| NZ595918A (en) | Genetic markers for risk management of atrial fibrillation and stroke | |
| WO2010062960A3 (fr) | Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d'une maladie intestinale inflammatoire | |
| NZ589863A (en) | Genetic markers for weight management and methods of use thereof | |
| NZ600235A (en) | Methods and compositions for the assessment of drug response | |
| WO2009086215A3 (fr) | Analyse de voies de phénotypes de culture de cellules et utilisations de celle-ci | |
| WO2011153354A8 (fr) | Procédés et kits de détection in situ de séquences de nucléotides | |
| WO2008028031A3 (fr) | Marqueurs et méthodes d'évaluation et de traitement de recocolite hémorragique et de troubles associées à l'aide d'un panel de 43 gènes | |
| MX2010005060A (es) | Identificacion y mapeo a base de microarreglos de adn de puntos de ruptura de translocacion equilibrados. | |
| WO2013090386A3 (fr) | Procédés et ensembles pour détection in situ à température ambiante d'un acide nucléique cible dans un échantillon biologique | |
| WO2013132074A3 (fr) | Test de génotypage pour évaluer le risque d'autisme | |
| WO2016133380A8 (fr) | Procédés et nécessaires de détection de polymorphisme mononucléotidique (snp) pour prédire le rendement d'huile de palme d'un plant de palmiers à huile d'essai | |
| WO2012080359A3 (fr) | Gènes de chm et risque de maladie de réaction de greffe contre hôte | |
| WO2007120955A3 (fr) | Gènes agissant sur les performances de la mémoire humaine | |
| WO2009147658A3 (fr) | Compositions et procédés pour le diagnostic, le pronostic et le traitement d'un mésothéliome | |
| WO2016156575A3 (fr) | Prédicteurs génétiques d'une réponse à un traitement par des antagonistes de crhr1 | |
| AR068526A1 (es) | Metodos para identificar variaciones de secuencias de nucleotidos (polimorfismos o mutaciones) en sujetos poliploides mediante un metodo de secuenciacion terminado con un dideoxinucleotido trifosfato (ddntp) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |